Update on cystic fibrosis-related bone disease: a special focus on children

Area of Science:

• Pediatric Endocrinology
• Pulmonology
• Bone Metabolism

Background:

• Cystic Fibrosis (CF) is associated with a high prevalence of low bone mineralization in adults, including osteopenia (up to 85%) and osteoporosis (10-34%).
• Bone health in children with CF is less clear due to varying study methodologies and growth-related factors.
• Known risk factors for poor bone health in CF include malnutrition, inflammation, vitamin deficiencies (D and K), hormonal imbalances, and medication side effects.

Purpose of the Study:

• To highlight the significant burden of low bone mineralization in cystic fibrosis patients.
• To emphasize the critical role of puberty in bone mass acquisition and the need for careful monitoring.
• To advocate for early and continuous strategies to prevent and manage CF-related bone disease.

Main Methods:

• Review of existing literature on bone health in pediatric and adult cystic fibrosis populations.
• Identification of established risk factors contributing to bone disease in CF.
• Analysis of the importance of bone mineral density monitoring and preventive care.

Main Results:

• Adult CF patients exhibit a high prevalence of osteopenia and osteoporosis.
• Discordant findings in pediatric studies suggest methodological challenges.
• Puberty represents a key period for achieving peak bone mass, requiring focused attention.

Conclusions:

• Optimizing bone health in cystic fibrosis necessitates proactive management from childhood through adolescence.
• Regular bone mineral density monitoring is essential for early detection and intervention.
• Comprehensive strategies addressing nutritional, inflammatory, and hormonal factors are vital to minimize bone disease in CF patients.